Halyard Health, a global supplier of medical devices and solutions, is selling its Indian subsidiary’s Surgical and Infection Prevention (S&IP) business division to Owens & Minor for ₹45 billion (US$710 million).
The transaction confirms investor appetite and growing opportunities in India’s healthcare sector. “With a population that is soon going to exceed China’s, India’s healthcare needs are burgeoning,” said Akil Hirani, the managing partner at Majmudar & Partners, who led a team advising Halyard on Indian law matters. “Hospital chains, diagnostic clinics, life sciences companies doing drug discovery, and medical devices firms are seeing a huge potential and are being aggressively pursued by strategic and financial investors.”
S&IP provides healthcare supplies and solutions that target the prevention of healthcare-associated infections. Its portfolio of surgical and infection prevention offerings includes sterilization wraps, surgical drapes and gowns, facial protection, protective apparel and medical exam gloves.
You must be a
subscribersubscribersubscribersubscriber
to read this content, please
subscribesubscribesubscribesubscribe
today.
For group subscribers, please click here to access.
Interested in group subscription? Please contact us.
你需要登录去解锁本文内容。欢迎注册账号。如果想阅读月刊所有文章，欢迎成为我们的订阅会员成为我们的订阅会员。
